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Abstract 
Atrial fibrillation (AF) is responsible for up to one-third of ischemic strokes and associated with silent cerebral infarc-
tions and transient ischemic attacks. Any method that predicts the stroke or unmasks the silent PAF would contribute 
to the treatment of ischemic stroke. Intraatrial conduction time (ICT) has been shown to be associated with intermit-
tent AF. In this study, we evaluated the value of ICT detected by transthoracic echocardiography in normal popula-
tion and in patients with cryptogenic stroke (CS) as a risk factor for stroke. The patients with CS and with normal left 
ventricular function without valvular disease are included in group 1. Patients with atypical symptoms admitted to 
cardiology clinics without any risk factor for cardiac disease and found to be normal constituted group 2. Age, gender, 
weight, height, echocardiographic parameters and ICT were compared between groups. 63 and 64 subjects were 
included in group 1 and 2, respectively. Two groups were similar according to age and gender. Among the param-
eters studied, left atrial diameter and height of the patients were significantly higher in group 1 (40 ± 2 vs 37 ± 4 mm, 
p < 0.001 and 167 ± 9 vs 163 ± 9 cm p = 0.027, respectively). ICT was significantly higher in group 1 (131 ± 15 vs 
118 ± 13 ms, respectively, p < 0.000). According to ROC analysis, a cut point of 124 ms for ICT with a sensitivity of 
74 % and specificity of 73 % in patients with CS (p < 0.001). This study show us, the measurements the ICT determined 
by means of echocardiography is longer in patients with CS. This simple and noninvasive technique can be applied 
widely and lead the clinicians to adopt the use of diagnostic and the treatment procedures.
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Background
Atrial fibrillation (AF) is responsible for up to one-third 
of ischemic strokes and associated with silent cerebral 
infarctions and transient ischemic attacks (TIA; Mohr 
1988). The self-terminating and often asymptomatic 
nature of paroxysmal AF may lead to its underdiagno-
ses. We suggest that a significant proportion of the unex-
plained strokes or TIA can be due to undiagnosed AF 
(Sanna et al. 2014). Any method that predicts the stroke 
or unmasks the silent AF would contribute to the treat-
ment of ischemic stroke. Intraatrial conduction time 
(ICT) has been shown to be associated with intermit-
tent AF (Kinay et  al. 2002). Intraatrial conduction time 
is commonly measured by invasive electrophysiological 
methods, and this measurement shows congruity with 
non-invasive echocardiographic calculation (Karaca et al. 
2007). In this study, we aimed to investigate the value of 
ICT in the normal population and cryptogenic stroke 
(CS) patients by using the noninvasive method of tran-
sthoracic echocardiography (TTE).
Results and discussion
Groups 1 and 2 were constituted of 63 and 64 subjects, 
respectively. Baseline characteristics and ICT measure-
ment of the study population are presented in Table  1. 
The two groups were similar according to age and gen-
der. Among the parameters studied, left atrial diameter 
and height of the patients were significantly higher in 
group 1 (40 ± 2 vs 37 ± 4 mm, p < 0.001 and 167 ± 9 vs 
163 ± 9 cm p=0.027, respectively). ICT was significantly 
longer in group 1 (131 ± 16 vs 118 ± 13 ms, respectively, 
p < 0.000).
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In the present study, we found that ICT was prolonged 
in patients with CS compared with healthy subjects 
(group 1 vs group 2; 131 ± 15 vs 118 ± 13 ms, p < 0.000).
According to ROC analysis, a cut point of 124 ms for ICT 
identified the patients at risk of CS with a sensitivity of 
74 % and specificity of 73 % (p < 0.001, Fig. 1).
Cryptogenic stroke has a devastating clinical outcome. 
Its cause is unknown even after vigorous neurological, 
radiological and other laboratory evaluation. It is well 
established that the presence of AF is associated with 
an almost fivefold increased risk of stroke (Wolf et  al. 
1991). Silent AF and other cardiac sources may be partly 
responsible for CS and yet still difficult to disclose. Other 
risk factors related to stroke and silent AF may be value 
for the approach to this patient population.
The prolongation of ICT and inhomogeneous propaga-
tion of sinus impulses are well known electrophysiological 
characteristics in patients with AF (Villani et  al. 1996; 
Dogan et al. 2012). Subclinical atrial dilatation may be the 
cause and substrate of decremental conduction proper-
ties which may lead to inducible episodes of AF (Cozma 
et al. 2006).
Intraatrial conduction time can be determined inva-
sively in the EP lab. A previous study by our group has 
shown that there was a significant correlation between 
ICT measurement determined by transesophageal echo-
cardiography and invasive electrophysiological study 
(Karaca et  al. 2007). A limited number of studies have 
revealed increased episodes of AF in patients with pro-
longed ICT. Another study has reported that this method 
predicted AF in patients with a long ICT detected dur-
ing open heart surgery following coronary by pass opera-
tion (Karaca et al. 2012). TEE was, however, found to be a 
useful tool for measuring ICT. There is a significant asso-
ciation between ICT and recurrence of AF (Kinay et  al. 
2002). In a previous study, investigators simultaneously 
measured the time interval between the electrocardio-
graphic P wave and the mitral “a” wave using transtho-
racic Doppler echocardiography, and they compared this 
noninvasive ICT measurement with the invasive method 
(Fuenmayor et  al. 2002). They concluded that transtho-
racic Doppler echocardiography combined with surface 
electrocardiography could be used for measuring the ICT 
with a similar accuracy as other more invasive methods. 
Technical improvements made this measurement more 
accurate and feasible.
Our study revealed that ICT detected by echocardiog-
raphy was prolonged in patients with CS when compared 
to the normal population. Left atrial size also increased in 
group 1. Although this study was not designed to detect 
silent AF episodes in the groups, increased conduction 
time and left atrial enlargement are known as AF trig-
gers. One can only speculate that group 1 patients may 
have increased episodes of AF. This study shows that 
ICT calculated by echocardiography was prolonged in 
patients with CS. One electrophysiological study showed 
the increased atrial vulnerability in young stroke patients 
with atrial septal abnormalities (Berthet et al. 2000).
Silent AF episodes can easily be detected in patients 
with implanted devices either directly from interrogation 
of the device or via remote monitoring (Lima et al. 2015; 
Healey et al. 2013). The CRYSTAL AF study showed that 
AF was more frequently detected with insertable cardiac 
monitors than with conventional follow-up in patients 
with a recent CS. In that study, only age and prolonged 
PR interval at enrollment were associated with AF. 
Intrinsic PR prolongation has been consistently demon-
strated to be associated with AF as it represents intrinsic 
atrial conduction disease (Sanna et al. 2014). In patients 
without a cardiac device, it is very difficult to detect 
Table 1 Baseline characteristics and  ICT measurement 
of the study population
EF ejection fraction, ICT intraatrial conduction time, LA left atrium
Variables Group 1 (n = 63) Group 2 (n = 64) p value
Age, years 62 ± 10 62 ± 9 NS
Male/female 38/26 39/24 NS
Height, cm 167 ± 9 163 ± 9 0.027
Weight, kg 75 ± 1 76 ± 1 NS
LA dimension 40 ± 2 37 ± 4 <0.001
EF 57.2 58.5 NS
ICT 131 ± 15 118 ± 13 <0.000
Fig. 1 Receiver operating curve of intraatrial conduction time for 
cryptogenic stroke
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AF episodes. Our study results may reflect a practical 
approach to overcome this difficulty.
In a recent study, the EMBRACE trial, premature atrial 
beats were found to be associated with silent episodes 
of AF in Holter recordings in patients with cryptogenic 
emboli (Gladstone et  al. 2015). Prolonged ICT may be 
associated with left atrial mechanical remodeling and 
dysfunction, both of which may be substrates for throm-
boembolism in CS patients. Whether increased atrial 
premature beats, p wave dispersion or ICT increase the 
tendency to tromboemboli by possibly increased AF 
episodes or by some unknown subclinical atrial pathol-
ogy unrelated with AF is yet to be demonstrated. Since 
there is no clinical data supporting the use of anticoagu-
lation regarding the prolonged ICT, indication for antico-
agulation should be based on current recommendations 
(Glotzer and Ziegler 2013).
Limitations
The number of subjects was too small to generalize the 
results. Although this study was not designed to reveal 
the relationship between PAF and ICT, it shows an asso-
ciation between ICT and stroke.
Conclusions
This study shows that ICT measured by echocardiogra-
phy was prolonged in patients with CS. This technique 
can be applied widely and may lead clinicians to insist on 
monitoring patients to reveal silent AF. This is especially 
noteworthy if the presence of AF would likely change 
the current therapeutic approach and provide additional 
diagnostic tools for these particular patients.
Methods
A total of 285 consecutive patients diagnosed with cer-
ebrovascular accident in our neurology clinic between 
April 2014 and January 2015 were investigated for pos-
sible CS. All patients were prospectively evaluated and 
regularly underwent clinical and instrumental evalu-
ation. Patients had routine blood tests (i.e. full blood 
count, clotting, C-reactive protein, erythrocyte sedi-
mentation rate, liver function, renal function, thyroid 
function, electrolytes, and lipid profile) after the stroke 
episode. Thrombophilia screening, vasculitis screening 
and genetic tests, where appropriate, were performed 
for patients with CS or those younger than 45. We did 
not enroll 142 patients with stroke in whom the cause of 
stroke was identified initially. The remaining 143 patients 
with possible CS were considered for evaluation.
Of the 143 patients recruited for possible CS, 63 
stroke/TIA patients (38 males; mean age 62 ± 10 years) 
who were considered to have cryptogenic stroke 
after extensive radiological and cardiac investigations 
constituted group 1. Eighty patients who had exclusion 
criteria were not included in the study. All cases were 
reviewed by two senior neurologists and stroke was clas-
sified according to the TOAST classification (Adams 
et  al. 1993). The diagnosis of an ischaemic stroke was 
based on symptoms and signs of a sudden onset focal 
neurological deficit, lasting at least 24  h, with corre-
sponding findings on computerized tomography, mag-
netic resonance imaging scans. TIA was defined as a 
focal neurological deficit which resolved completely 
within 24 h without positive neurovascular imaging. We 
excluded patients with prior cerebrovascular accident, 
malignant arterial hypertension, uncontrolled diabetes 
mellitus, untreated hyperthyroidism, myocardial infarc-
tion or coronary bypass grafting history 1  month prior 
to stroke, valvular disease, documented history of AF or 
atrial flutter or presence of PFO. Patients with more than 
3 days follow up in intensive care unit or requiring intu-
bation due to respiratory failure were also excluded from 
the study.
Sixty-four patients (39 males; mean age 62 ± 9 years) 
with atypical symptoms admitted to cardiology clinics 
without any risk factor for cardiac disease and they were 
considered as healthy controls. Accordingly, they consti-
tuted group 2.
The echocardiography machine in the study provided 
real-time, simultaneous display of ECG and doppler 
echocardiogram of patients. Baseline echocardiography 
measurements recorded and compare with NORRE study 
(Kou et  al. 2014). After the routine echocardiography 
evaluation, ICT was measured. The beginning of the P 
wave was marked in modified lead DI, in which the right 
arm electrode was attached on the top right of the manu-
brium and the left arm electrode in the fifth intercostal 
space at the right parasternal line (Lewis lead). The last 
atrial activity was marked as the top of the A wave trace 
which was obtained from the left atrium free wall next to 
the mitral annulus with tissue Doppler recording (Fig. 2).
This study was approved by our hospital review board 
and the informed consent was obtained from each 
patient.
Statistical analysis; age, gender, weight, height, echo-
cardiographic parameters and ICT were compared 
between groups. Continuous variables are presented 
as mean  ±  SD, whereas dichotomous variables are 
described as numbers and percentages. The differ-
ences among the two groups were compared using the 
Chi-square test for categorical variables and Student’s t 
tests or Mann Whitney U test for continuous variables. 
A cut point of ICT for predicting of CS was calculated 
by using receiver operating curve (ROC) analysis, and 
its sensitivity and specificity were estimated. Statistical 
analysis was performed by using the Statistical Package 
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for Social Sciences, version 16 (SPSS Inc., Chicago, IL, 
USA). A p value <0.05 was considered to indicate statisti-
cal significance.
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